News Release

share on google plus
Text size
view with small font size
view with medium font size
view with large font size

May 25, 2012

Change in the Company Name of JEIL-KIRIN PHARMACEUTICAL INC.

Tokyo, Japan, May 25, 2012 --- Effective from 1st June 2012, JEIL-KIRIN PHARMACEUTICAL INC., a joint company of Kyowa Hakko Kirin Co., Ltd. ("Kyowa Hakko Kirin") and Jeil Pharmaceutical Co., Ltd., having its business of development and marketing of ethical drugs in Korea, will change its name to "Kyowa Hakko Kirin Korea Co., Ltd.".

<Reason for the change>
The reason for the company name change is being instituted to highlight the corporate brand image of "Kyowa Hakko Kirin" in Korean pharmaceutical market and to set up a goal to grow Kyowa Hakko Kirin Group as a global specialty pharma in one united body.

Company profile of Kyowa Hakko Kirin Korea Co., Ltd.

Established date May 24, 1991
Location 5F, Poonglim Bldg., 124, Teheran-ro, Gangnam-gu, Seoul 135-784, Korea
President & CEO Tae Se Kwon
Paid up capital 2.2 billion KRW
Shareholders Kyowa Hakko Kirin Co., Ltd. (90%), Jeil Pharmaceutical Co., Ltd. (10%)
Sales 43.4 billion KRW (2011)
Line of business Development and sale of ethical drugs in Korea
Main offices Head office: Seoul
Office: Busan, Daegu, Gwangiu, Daejeon, Gangwon

To Page Top